Harpoon Therapeutics, Inc.·4

Mar 26, 5:22 PM ET

Colowick Alan 4

4 · Harpoon Therapeutics, Inc. · Filed Mar 26, 2021

Insider Transaction Report

Form 4
Period: 2021-03-24
Transactions
  • Award

    Director Stock Option (right to buy)

    2021-03-24+20,33520,335 total
    Exercise: $19.63Exp: 2031-03-23Common Stock (20,335 underlying)
Footnotes (1)
  • [F1]The stock option vests in three equal annual installments measured from the date of grant, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION